Why partner with AstraZeneca?

We have a global commercial presence and strength in emerging markets, particularly in China. Our innovative medicines, many of which are developed in partnership with others, are used by millions of patients worldwide.


Total Revenue


Collaboration Revenue


major or strategically important deals completed in last three years


collaborations worldwide help us access the best science, stimulate innovation and accelerate delivery of new medicines for unmet medical needs




manufacturing sites in 16 countries


invested in R&D


of pipeline has a precision medicine approach

For year ending 31 December 2019

Pushing the boundaries of science to deliver life-changing medicines

Science is what drives AstraZeneca. We keep pushing the boundaries of science to deliver life-changing medicines that address significant unmet medical need in diseases affecting millions of people around the world.

Encouraging innovation and inspiring the next generation of start-ups

Veeva ID: Z4-27153
Date of Prep: Sept 2020